Experimental drug shows promise in restoring memory in Alzheimer’s model

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer’s disease.

Apogee files to go public, unveiling plans to make a play for Dupixent’s turf

Apogee Therapeutics launched last year with $169 million in private financing and is headed for an IPO. The startup was spun out of Paragon Therapeutics

June 23, 2023

Psychedelic Research Bulletin: May 2023 – Psychedelic Alpha

Comparing psychedelics Talk to any psychonaut and they will tell you there are (significant) differences between LSD, psilocybin, and mescaline. Look at brain scans and

June 29, 2023

Heated lawsuit between AdventHealth, MultiPlan attracts hospital lobbyists

A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.